Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 105827-78-9
2. N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide
3. 1-((6-chloro-3-pyridinyl)methyl)-4,5-dihydro-n-nitro-imidazol-2-amine
4. 1-((6-chloro-3-pyridinyl)methyl)-n-nitro-4,5-dihydro-1h-imidazol-2-amine
5. Imidacloprid [mi]
6. Imidacloprid [hsdb]
7. Bay Ntn 33893
8. Imidacloprid [mart.]
9. Mls001304087
10. Imidacloprid [green Book]
11. Hms2231f05
12. Hms3373h06
13. Bdbm50212288
14. Mfcd00468059
15. Advocate Component Imidacloprid
16. Akos015895351
17. Imidacloprid Component Of Advocate
18. Imidacloprid [ema Epar Veterinary]
19. Smr000718777
20. Db-042420
21. Ft-0631157
22. Ft-0656073
23. E79264
24. Ab00876233-04
25. A801327
26. J-007111
27. 1-(6-chloro-3-pyridylmethyl)-n-nitromidazolidin-2-ylideneamine
28. 1-((6-chloro-3-pyridinyl)methyl)-4,5-dihydro-n-nitro-1h-imidazol-2-amine
29. 1-[(6-chloropyridin-3-yl)methyl]-n-nitro-4,5-dihydro-1h-imidazol-2-amine
30. 2-chloro-5-{[2-(nitroamino)-4,5-dihydro-1h-imidazol-1-yl]methyl}pyridine
31. N-[1-[(6-chloranylpyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide
32. N-{1-[(6-chloro-3-pyridyl)methyl]-4,5-dihydroimidazol-2-yl}nitramide
33. N-(1-((6-chloropyridin-3-yl)methyl)-4,5-dihydro-1h-imidazol-2-yl)nitramide
Molecular Weight | 255.66 g/mol |
---|---|
Molecular Formula | C9H10ClN5O2 |
XLogP3 | 0.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 255.0523023 g/mol |
Monoisotopic Mass | 255.0523023 g/mol |
Topological Polar Surface Area | 86.3 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 319 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30998
Submission : 2016-09-21
Status : Inactive
Type : II
NDC Package Code : 70952-002
Start Marketing Date : 2018-04-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6166
Submission : 2016-10-03
Status : Active
Type : II
Certificate Number : R0-CEP 2020-259 - Rev 00
Issue Date : 2022-03-03
Type : Chemical
Substance Number : 2924
Status : Valid
Certificate Number : CEP 2021-285 - Rev 02
Issue Date : 2024-01-19
Type : Chemical
Substance Number : 2924
Status : Valid
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Imidacloprid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imidacloprid, including repackagers and relabelers. The FDA regulates Imidacloprid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imidacloprid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imidacloprid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imidacloprid supplier is an individual or a company that provides Imidacloprid active pharmaceutical ingredient (API) or Imidacloprid finished formulations upon request. The Imidacloprid suppliers may include Imidacloprid API manufacturers, exporters, distributors and traders.
click here to find a list of Imidacloprid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imidacloprid DMF (Drug Master File) is a document detailing the whole manufacturing process of Imidacloprid active pharmaceutical ingredient (API) in detail. Different forms of Imidacloprid DMFs exist exist since differing nations have different regulations, such as Imidacloprid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Imidacloprid DMF submitted to regulatory agencies in the US is known as a USDMF. Imidacloprid USDMF includes data on Imidacloprid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Imidacloprid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Imidacloprid suppliers with USDMF on PharmaCompass.
A Imidacloprid CEP of the European Pharmacopoeia monograph is often referred to as a Imidacloprid Certificate of Suitability (COS). The purpose of a Imidacloprid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Imidacloprid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Imidacloprid to their clients by showing that a Imidacloprid CEP has been issued for it. The manufacturer submits a Imidacloprid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Imidacloprid CEP holder for the record. Additionally, the data presented in the Imidacloprid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Imidacloprid DMF.
A Imidacloprid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Imidacloprid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Imidacloprid suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imidacloprid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imidacloprid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imidacloprid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imidacloprid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imidacloprid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imidacloprid suppliers with NDC on PharmaCompass.
Imidacloprid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imidacloprid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imidacloprid GMP manufacturer or Imidacloprid GMP API supplier for your needs.
A Imidacloprid CoA (Certificate of Analysis) is a formal document that attests to Imidacloprid's compliance with Imidacloprid specifications and serves as a tool for batch-level quality control.
Imidacloprid CoA mostly includes findings from lab analyses of a specific batch. For each Imidacloprid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imidacloprid may be tested according to a variety of international standards, such as European Pharmacopoeia (Imidacloprid EP), Imidacloprid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imidacloprid USP).
LOOKING FOR A SUPPLIER?